West T Eoin, von Saint André-von Arnim Amélie
1 Division of Pulmonary & Critical Care Medicine, Department of Medicine, and.
Ann Am Thorac Soc. 2014 Nov;11(9):1341-50. doi: 10.1513/AnnalsATS.201410-481PS.
Clinicians caring for patients infected with Ebola virus must be familiar not only with screening and infection control measures but also with management of severe disease. By integrating experience from several Ebola epidemics with best practices for managing critical illness, this report focuses on the clinical presentation and management of severely ill infants, children, and adults with Ebola virus disease. Fever, fatigue, vomiting, diarrhea, and anorexia are the most common symptoms of the 2014 West African outbreak. Profound fluid losses from the gastrointestinal tract result in volume depletion, metabolic abnormalities (including hyponatremia, hypokalemia, and hypocalcemia), shock, and organ failure. Overt hemorrhage occurs infrequently. The case fatality rate in West Africa is at least 70%, and individuals with respiratory, neurological, or hemorrhagic symptoms have a higher risk of death. There is no proven antiviral agent to treat Ebola virus disease, although several experimental treatments may be considered. Even in the absence of antiviral therapies, intensive supportive care has the potential to markedly blunt the high case fatality rate reported to date. Optimal treatment requires conscientious correction of fluid and electrolyte losses. Additional management considerations include searching for coinfection or superinfection; treatment of shock (with intravenous fluids and vasoactive agents), acute kidney injury (with renal replacement therapy), and respiratory failure (with invasive mechanical ventilation); provision of nutrition support, pain and anxiety control, and psychosocial support; and the use of strategies to reduce complications of critical illness. Cardiopulmonary resuscitation may be appropriate in certain circumstances, but extracorporeal life support is not advised. Among other ethical issues, patients' medical needs must be carefully weighed against healthcare worker safety and infection control concerns. However, meticulous attention to the use of personal protective equipment and strict adherence to infection control protocols should permit the safe provision of intensive treatment to severely ill patients with Ebola virus disease.
照顾感染埃博拉病毒患者的临床医生不仅必须熟悉筛查和感染控制措施,还必须熟悉重症疾病的管理。通过将几次埃博拉疫情的经验与危重病管理的最佳实践相结合,本报告重点关注埃博拉病毒病重症婴幼儿、儿童和成人的临床表现及管理。发热、疲劳、呕吐、腹泻和厌食是2014年西非疫情最常见的症状。胃肠道大量体液流失导致容量耗竭、代谢异常(包括低钠血症、低钾血症和低钙血症)、休克及器官衰竭。明显出血情况并不常见。西非的病死率至少为70%,出现呼吸、神经或出血症状的个体死亡风险更高。尽管可以考虑几种实验性治疗方法,但目前尚无经证实有效的抗病毒药物来治疗埃博拉病毒病。即使在没有抗病毒治疗的情况下,强化支持治疗也有可能显著降低迄今报道的高病死率。最佳治疗需要认真纠正体液和电解质流失。其他管理考虑因素包括寻找合并感染或重叠感染;治疗休克(使用静脉输液和血管活性药物)、急性肾损伤(采用肾脏替代治疗)和呼吸衰竭(采用有创机械通气);提供营养支持、控制疼痛和焦虑以及心理社会支持;以及采用策略减少危重病并发症。在某些情况下,心肺复苏可能是合适的,但不建议使用体外生命支持。在其他伦理问题中,必须仔细权衡患者的医疗需求与医护人员安全及感染控制问题。然而,严格注意个人防护设备的使用并严格遵守感染控制规程,应能安全地为埃博拉病毒病重症患者提供强化治疗。